According to Bloomberg.com, Mexico’s Genomma Lab Internacional SAB rose the most in July as Chief Executive Officer Rodrigo Herrera said the company was on pace to meet its sales growth projections this year.
The drug company is “comfortable” with the forecast of net sales growth of 5.2 percent in 2015, Herrera said in a phone interview with Bloomberg.com on Friday July 17th.
Its fourth-quarter results shocked shareholder Westwood International Advisors Inc., according to Richard Dolhun, an analyst at the firm. Genomma is due to publish its second-quarter earnings and hold a conference call with investors this week.
“We’re going to hold their feet to the fire,” Dolhun, whose firm oversees $5 billion in equities including Genomma, said by phone. “They have to have a tight message. They have to hit on what they’ve promised.”
Shares of Genomma increased 3.1 percent to 16.29 pesos at 12:35 p.m. in Mexico City. The benchmark IPC equity index rose 0.6 percent on Monday July 20th.
more recommended stories
Fitch confirms Mexico’s good rating, but warns of AMLO risks
The rating agency Fitch Ratings confirmed the credit rating of.
“Yucatan’s good public safety is attracting foreign direct investment”: Expert
“Just a few years ago, Yucatan.
Members of the “Antorchista” Mexican political organization march the streets of Mérida
According to estimations of the state.
Mexico, Inditex fifth most important market in 2017
The expansion and growth of the.
Explosions rattle Austin, Texas
A deadly string of unsolved bombings in.
Quintana Roo will have Port Facilities Protection Code
“As part of the security adjustments.
Mexico celebrates Benito Juarez “The Lincoln of Mexico”
Benito Juarez’s birthday (March 21) is.
Presidential candidate José A. Meade warns about influence of organized crime in Mexican elections
One of the concerns for this.
K’u’uk: contemporary cuisine or pure alchemy?
Acknowledged at the Food and Travel.
Mérida, one of the best cities to live in Mexico (and the world)
Dan Prescher wrote an article for.